| Literature DB >> 23209903 |
Assem Hedayat1, Hamdi Elmoselhi, Ahmed Shoker.
Abstract
Objective. Nanotechnology has the potential to improve hemodialysis membrane technology. Thus, a major objective is to understand how to enhance toxic solute fluxes across these membranes. The aim of this concept building study is to review the application of irreversible thermodynamic (IT) to solute fluxes. Methods. We expanded the application of the Nernst-Planck equation to include the Kedem-Katchalsky equation, pH, membrane thickness, pore size, and electric potential as variables. Results. (1) Reducing the membrane's thickness from 25 μm to 25 nm increased the flux of creatinine, β(2)-microglobulin, and tumor necrosis factor-α (TNF-α) by a thousand times but prevented completely albumin flux, (2) applying an electric potential of 50-400 mV across the membrane enhanced the flux of the respective molecules by 71.167 × 10(-3), 38.7905 × 10(-8), and 0.595 × 10(-13) mol/s, and (3) changing the pH from 7.35 to 7.42 altered the fluxes minimally. Conclusions. The results supported an argument to investigate the application of IT to study forces of fluxes across membranes. Reducing the membrane's thickness-together with the application of an electrical potential-qualities achievable by nanotechnology, can enhance the removal of uremic toxins by many folds. However, changing the pH at a specific membrane thickness does not affect the flux significantly.Entities:
Year: 2012 PMID: 23209903 PMCID: PMC3502860 DOI: 10.1155/2012/718085
Source DB: PubMed Journal: Int J Nephrol
Figure 1Effect of pH and membrane thickness on solute flux as calculated from J = −DeffAKdiff(dC/dx) − (DeffACzF/RT)(dV/dx) − (DeffAC/x)(−4.606 pH − 2.303logP) + KconvACJ. Creatinine molecular volume 110.55 Å3, β2-microglobulin molecular volume 14,514.81 Å3, and tumor necrosis factor-α molecular volume 31,979.13 Å3 (Fluxes are expressed as mol/s; P < 0.0001 and R2 > 0.95 in all instances).
Figure 2Effect of electrical potential and membrane thickness on solute flux as calculated from J = −DeffAKdiff(dC/dx) − (DeffACzF/RT)(dV/dx) − (DeffAC/x)(−4.606 pH − 2.303logP) + KconvACJ. Creatinine molecular volume 110.55 Å3, β2-microglobulin molecular volume 14,514.81 Å3 and tumor necrosis factor-α molecular volume 31,979.13 Å3. (Fluxes are expressed as mol/s; P < 0.0001 and R2 > 0.95 in all instances; Note the major impact of mV and thickness on fluxes.)
Normal concentration of selected uremic toxin molecules in the blood and sieving coefficient.
| Molecule | Normal concentration* | Sieving coefficient** |
|---|---|---|
| Creatinine | 10.2 mg/L [ | 1.0 |
|
| <2.0 mg/L [ | 0.35 |
| Tumor necrosis factor- | 13.3 ± 3.0 ng/L [ | 0.2 |
*Used as Cbulk.
**Determined from sieving coefficient versus molecular weight illustration [46].